Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

MARKSANS PHARMA. vs IND. SWIFT - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    MARKSANS PHARMA. IND. SWIFT MARKSANS PHARMA./
IND. SWIFT
 
P/E (TTM) x 21.3 3.3 641.0% View Chart
P/BV x 3.9 - - View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 MARKSANS PHARMA.   IND. SWIFT
EQUITY SHARE DATA
    MARKSANS PHARMA.
Mar-23
IND. SWIFT
Mar-23
MARKSANS PHARMA./
IND. SWIFT
5-Yr Chart
Click to enlarge
High Rs7415 508.7%   
Low Rs397 595.4%   
Sales per share (Unadj.) Rs40.975.9 53.9%  
Earnings per share (Unadj.) Rs5.94.8 121.8%  
Cash flow per share (Unadj.) Rs7.010.1 69.3%  
Dividends per share (Unadj.) Rs0.500-  
Avg Dividend yield %0.90-  
Book value per share (Unadj.) Rs38.5-130.1 -29.6%  
Shares outstanding (eoy) m453.1654.16 836.7%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.40.1 993.8%   
Avg P/E ratio x9.72.2 439.5%  
P/CF ratio (eoy) x8.11.0 772.5%  
Price / Book Value ratio x1.5-0.1 -1,808.6%  
Dividend payout %8.50-   
Avg Mkt Cap Rs m25,631572 4,479.0%   
No. of employees `000NANA-   
Total wages/salary Rs m2,394637 375.5%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m18,5214,110 450.7%  
Other income Rs m593119 500.4%   
Total revenues Rs m19,1154,228 452.1%   
Gross profit Rs m3,3931,026 330.7%  
Depreciation Rs m519287 180.9%   
Interest Rs m91598 15.3%   
Profit before tax Rs m3,377260 1,296.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m7230-   
Profit after tax Rs m2,653260 1,019.0%  
Gross profit margin %18.325.0 73.4%  
Effective tax rate %21.40-   
Net profit margin %14.36.3 226.1%  
BALANCE SHEET DATA
Current assets Rs m16,9972,734 621.7%   
Current liabilities Rs m3,6549,363 39.0%   
Net working cap to sales %72.0-161.3 -44.7%  
Current ratio x4.70.3 1,593.3%  
Inventory Days Days6115 5.0%  
Debtors Days Days82929 8.8%  
Net fixed assets Rs m5,2463,758 139.6%   
Share capital Rs m453108 418.3%   
"Free" reserves Rs m16,998-7,155 -237.6%   
Net worth Rs m17,452-7,047 -247.6%   
Long term debt Rs m04,031 0.0%   
Total assets Rs m22,2426,492 342.6%  
Interest coverage x38.01.4 2,646.2%   
Debt to equity ratio x0-0.6 -0.0%  
Sales to assets ratio x0.80.6 131.5%   
Return on assets %12.313.2 93.4%  
Return on equity %15.2-3.7 -411.5%  
Return on capital %19.9-28.4 -69.8%  
Exports to sales %068.8 0.0%   
Imports to sales %7.35.3 137.8%   
Exports (fob) Rs mNA2,827 0.0%   
Imports (cif) Rs m1,348217 620.9%   
Fx inflow Rs m6,4912,947 220.3%   
Fx outflow Rs m1,348313 430.2%   
Net fx Rs m5,1432,634 195.3%   
CASH FLOW
From Operations Rs m2,374730 325.0%  
From Investments Rs m-2,592-293 883.3%  
From Financial Activity Rs m1,978-466 -424.9%  
Net Cashflow Rs m1,760-29 -6,165.7%  

Share Holding

Indian Promoters % 43.9 55.6 78.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 20.3 0.0 -  
FIIs % 15.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 56.2 44.4 126.4%  
Shareholders   237,377 14,219 1,669.4%  
Pledged promoter(s) holding % 0.0 42.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare MARKSANS PHARMA. With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on MARKSANS PHARMA. vs IND. SWIFT

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

MARKSANS PHARMA. vs IND. SWIFT Share Price Performance

Period MARKSANS PHARMA. IND. SWIFT S&P BSE HEALTHCARE
1-Day -0.17% 8.28% 1.13%
1-Month -1.34% -2.97% -0.80%
1-Year 108.30% 161.80% 61.74%
3-Year CAGR 44.80% 59.03% 18.14%
5-Year CAGR 43.44% 27.79% 19.77%

* Compound Annual Growth Rate

Here are more details on the MARKSANS PHARMA. share price and the IND. SWIFT share price.

Moving on to shareholding structures...

The promoters of MARKSANS PHARMA. hold a 43.9% stake in the company. In case of IND. SWIFT the stake stands at 55.6%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of MARKSANS PHARMA. and the shareholding pattern of IND. SWIFT.

Finally, a word on dividends...

In the most recent financial year, MARKSANS PHARMA. paid a dividend of Rs 0.5 per share. This amounted to a Dividend Payout ratio of 8.5%.

IND. SWIFT paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of MARKSANS PHARMA., and the dividend history of IND. SWIFT.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine Sensex Today Rallies 550 Points| Nifty Tops 22,250 | Power Stocks Shine(10:30 am)

Asian markets traded lower, while the US stock indices ended higher overnight with the S&P 500 hitting a record closing high ahead of key economic data.